Juniper Pharmaceuticals I...

NASDAQ: JNP · Real-Time Price · USD
11.50
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM

Juniper Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Product Segments Revenue 32.69M 41.51M 22.16M
Product Segments Revenue Growth -21.25% +87.29% n/a
Services Segment Revenue 17.29M 13.06M 11.65M
Services Segment Revenue Growth +32.35% +12.14% n/a

Revenue by Geography

Period Ending Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012
Other Countries Revenue 2.69M 2.68M 3.05M 4.23M 2.03M 8.57M
Other Countries Revenue Growth +0.30% -11.97% -27.92% +107.94% -76.25% n/a
Switzerland Revenue 33.26M 27.3M 22.41M 17.86M n/a 17.26M
Switzerland Revenue Growth +21.84% +21.83% +25.48% n/a n/a n/a
United States Revenue 10.46M 19.95M 7.68M 10.37M n/a n/a
United States Revenue Growth -47.56% +159.93% -26.00% n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 7.08M 4.51M 3.67M 3.75M 5.01M 4.8M 4.6M 3.37M 3.62M 3.73M 3.41M 2.56M 2.84M 2.9M
Selling, General, and Administrative Revenue Growth +57.08% +22.67% -2.13% -25.11% +4.46% +4.35% +36.50% -6.98% -2.92% +9.44% +33.31% -10.06% -1.76% n/a
Research and Development Revenue 1.05M 974K 1.57M 2.29M 1.65M 1.35M 1.44M 2.3M 3.55M 1.75M 1.83M 1.6M 2.13M 1.38M
Research and Development Revenue Growth +8.32% -38.16% -31.25% +39.02% +22.44% -6.66% -37.41% -35.10% +102.63% -4.47% +14.77% -25.05% +54.05% n/a
Sales and Marketing Revenue 563K 419K 553K 517K 410K 379K 349K 259K 379K 272K 308K 338K 282K 321K
Sales and Marketing Revenue Growth +34.37% -24.23% +6.96% +26.10% +8.18% +8.60% +34.75% -31.66% +39.34% -11.69% -8.88% +19.86% -12.15% n/a